Metformin ($BADDIE) is LIVE for trading on https://t.co/CBgVLuodlT & other platforms.
Metformin is a 60‑year‑old safe pharmaceutical compound with a brand‑new mission to extend healthy human life.
https://t.co/dyqMiFOhHj
$BADDIE: KM9hApLdcM3EA5PnPA9DaNjyoJtbaJWYXjwPp3Ur9Xs
What if our descendants look back at our acceptance of aging the way we look back at medieval medicine?
We interviewed them.
Dystopian futures are easy to imagine. Optimistic futures take vision and courage to build.
VOICES FROM 2099:
LIVE today —Longevity research is entering its open-source era.
@LinusPeters, founder of @LongevityVentur joins us LIVE to explore how Metformin, decentralized labs, and collective intelligence are pushing the frontier of age-reversal tech.
🗓️ Today | 9AM EST 👇
https://t.co/REh699ppPm
Vitalik just rt'd @LinusPeters
He's founder of Swedish Longevity Cluster
Support his Metformin longevity research:
$BADDIE ($57k mc)
KM9hApLdcM3EA5PnPA9DaNjyoJtbaJWYXjwPp3Ur9Xs
Only on @pumpdotscience
Backed by the Solana Foundation
DeSci.
Countdown begins! The first of three launches on @pumpdotscience is lifting off today at 10am PT / 7pm CET.
Our mission at Rapamycin Longevity Lab (@omipalRLL) is to explore how far we can push the boundaries of human longevity through mTOR inhibitor based combinational therapies.
Launch schedule for the week
1⃣ Sept 15, 10am PT / 7pm CET – Doxycycline ($DOCS)
2⃣ Sept 17, 10am PT / 7pm CET – Omipalisib + Doxycycline ($OMIDOCS)
3⃣ Sept 19, 11am PT / 8pm CET – Rapamycin + Doxycycline ($RAPADOCS)
All of this is the result of a powerful combination of decentralized science, crypto and longevity research!
Metformin ($BADDIE) is LIVE for trading on https://t.co/CBgVLuodlT & other platforms.
Metformin is a 60‑year‑old safe pharmaceutical compound with a brand‑new mission to extend healthy human life.
https://t.co/dyqMiFOhHj
$BADDIE: KM9hApLdcM3EA5PnPA9DaNjyoJtbaJWYXjwPp3Ur9Xs
Rapamycin Longevity Lab is proud to announce that the world-leading researcher Brian Kennedy (@BKennedy_aging) will join the lab as a scientific advisor. We are also thrilled to welcome Kamil Pabis (@Aging_Scientist), a great researcher from Brian’s lab, who will take on the role of scientific lead at Rapamycin Longevity Lab. Together, we will evaluate and explore the opportunities of using @pumpdotscience as a platform to accelerate and fund longevity research in a new way. Now in mid September we are launching three promising longevity interventions on the platform. More details about this will be shared in the coming week. A very warm welcome to Brian and Kamil! We look forward to pushing the boundaries of longevity science together!